Use of neuromuscular blocking agents in acute respiratory distress syndrome.

ABSTRACT: Acute respiratory distress syndrome is the result of an acute inflammatory response of the lungs, causing severe hypoxemia. A variety of therapeutic modalities have been extensively studied, with only a few demonstrating improvement in survival. Specifically, mechanical ventilation with use of low tidal volumes, prone positioning, and treatment with neuromuscular blocking agents have proven beneficial. This article focuses on the utilization of neuromuscular blocking agents in this entity. In particular, we briefly review the mechanism of action of neuromuscular blockades, the latest published evidence supporting their use in acute respiratory distress syndrome, and current recommendations for their utilization in clinical practice.

SUBMITTER: Tsai-Nguyen G 

PROVIDER: S-EPMC5914437 | biostudies-other | 2018 Apr

REPOSITORIES: biostudies-other